Navigation Links
Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million
Date:8/6/2008

8. Gross margin for the second quarter of 2008 was unfavorably impacted by negative gross margin incurred at the Company's Sheffield, UK operating unit.

Selling, general and administrative expenses were $14.9 million for the second quarter 2008, compared to $8.0 million in the second quarter 2007. The year-over-year increase was primarily driven by the inclusion of $2.5 million of ongoing expense from the Company's recent acquisitions, $2.5 million increase in employee related expense including non-cash stock based compensation and $1.4 million in professional fees and expenses incurred from the review of accounting irregularities at the Company's Sheffield, UK operating unit. Selling, general and administrative expenses were also higher due to ongoing initiatives to improve management oversight and operational performance at the Company's Sheffield, UK operating unit.

Operating income for the second quarter of 2008 was $12.5 million, up 86.8% from $6.7 million for the second quarter 2007 and up 30.6% from $9.6 million in the first quarter 2008. Operating margin for the second quarter 2008 was 11.4%, an increase from 9.6% and 9.4% for the second quarter 2007 and the first quarter 2008, respectively.

The second quarter 2008 included a non-cash gain of $1.4 million from an increase in the fair value of the Company's interest rate derivatives due to higher interest rates, compared to a non-cash gain of $0.7 million in the second quarter 2007.

Income tax expense for the second quarter 2008 was $4.9 million, compared to $1.4 million for the second quarter of 2007. The Company's overall corporate tax rate in the second quarter increased over the second quarter of 2007 due to a net loss at its Sheffield, UK facility, which carries a lower tax rate than the U.S. statutory rate. The Company also incurred a $0.7 million tax expense related to Symmetry's ongoing assessment of reserves for uncertain tax provisions as required by FASB FIN48.

Ne
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Symmetry Medical to Report Second Quarter 2008 Financial Results on August 6, 2008
2. Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million
3. Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008
4. Symmetry Medical Reports Full Year 2007 Financial Results
5. Symmetry Medical Delays 10-K Filing to Complete Review
6. Symmetry Medical to Expand Malaysian Operations
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
9. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
10. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
11. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... use among young people has spiked, with 29.3 percent ... at least once and 17 percent admitting to regular use ... ‘Yes to Life,’ volunteers from the Church of Scientology of ... information about drugs, to help reverse this alarming trend. , ... Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies of ...
(Date:8/1/2014)... appetite and whole-body metabolism. A protein known as PPARγ ... and body weight, but the identity of the neurons ... new study in the Journal of Clinical Investigation ... neuron known as pro-opiomelanocortin (POMC) neurons is critical in ... and colleagues at Yale University School of Medicine found ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. ... approved a new drug, Jardiance, to help fight type ... alone or added to existing treatment regimens to control ... Dr. Curtis Rosebraugh, director of the Office of Drug ... and Research, said in an agency statement. The ...
(Date:8/1/2014)... Summer is here, and with it comes the season of ... can be a pain for dogs. Animal Emergency & Referral ... get rid of ticks and prevent them completely. , Female ... which is why they are so active during this season. ... and carry a number of diseases, including lyme disease, babesiosis ...
(Date:8/1/2014)... of a cancer diagnosis may improve health outcomes for ... by a researcher at the University of Houston (UH). ... intervention is the writing instruction. Otherwise, writing is just ... journal can be therapeutic, but oftentimes we don,t get ... not," said Qian Lu, assistant professor and director of ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
... Blood donors with hemochromatosis, a disorder in which iron ... a greater risk to blood safety than other donors, ... the National Heart, Lung, and Blood Institute (NHLBI). // ... or "blood letting" to remove excess iron from their ...
... Researchers at Harvard Medical School have looked at the use ... They find that the use of 20 therapies - from ... 1960s. A new survey reveals that complementary and alternative medicine ... has changed over the years. // ...
... heart disease can expect to live longer if they take ... for people with a high risk of stroke or heart ... - preventing clotting - and also reduces inflammation. A new ... US now reveals that aspirin reduces deaths from all causes ...
... found a cheap and non toxic method of treating Hepatitis, ... virus infects the liver, and in severe cases can lead ... through contact with the blood or body fluids of an ... HBV after a very bright and aware patient observed that ...
... heal wounds made inside the body during surgery without scarring. ... stops tissues sticking together to form painful scars. One of ... be used ,during keyhole surgery, which is now commonly preferred ... made from polyethylene glycol, is now undergoing clinical trials in ...
... relief for chronic pain, and should be studied for ... conference in Glasgow.,Dr William Notcutt of the James Paget ... used in his study - applied as a spray ... chronic pain. He announced the findings at the annual ...
Cached Medicine News:
(Date:8/1/2014)... N.C. , Aug. 1, 2014  With monumental ... learning to speak a second language. Clinical efficacy is ... agencies established under the ACA like PCORI are directing ... a variety of new entities and environments, the federal ... speak the new language of outcomes and managed markets ...
(Date:8/1/2014)... WASHINGTON , Aug. 1, 2014 In ... of treatments for sexual dysfunction, more than 60 doctors ... penned an open letter questioning the Food and Drug ... the most common form of male sexual dysfunction compared ... on the agency to act for women by approving ...
(Date:8/1/2014)... According to the new ... Anti infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, ... Pressure Relief Devices, NPWT) - Global Forecast to ... is expected to reach $18.3 Billion by 2019 ... CAGR of 3.2% from 2014 to 2019. ...
Breaking Medicine Technology:Pharmaceuticals Learning the Language of the New Healthcare Landscape 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 360+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
... Banner Health and ... jointly announce Banner Health,s system-wide conversion to Masimo rainbow® SET ... Health hospital will be cared for using the most technologically ... "The decision to convert our entire hospital system ...
... 2, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
Cached Medicine Technology:Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 2Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 3Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 4Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 5Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 6Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 2Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 3Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 4Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 5Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 6Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 7Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 8
Microalbumin Linearity Control...
Total IgE Control...
The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
The K-ASSAY hs-CRP Control Set is intended to be used as a consistent test sample of known concentrations for monitoring the performance of hs-CRP (high sensitive C-Reactive Protein) immunoturbimetri...
Medicine Products: